HomeATXS • NASDAQ
add
Astria Therapeutics Inc
Previous close
$6.64
Year range
$5.73 - $16.90
Market cap
374.72M USD
Avg Volume
249.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 29.59M | 55.74% |
Net income | -25.63M | 18.41% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 328.13M | 33.10% |
Total assets | 342.36M | 34.44% |
Total liabilities | 23.10M | 100.00% |
Total equity | 319.26M | — |
Shares outstanding | 56.43M | — |
Price to book | 1.67 | — |
Return on assets | -21.02% | — |
Return on capital | -22.02% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -25.63M | 18.41% |
Cash from operations | -17.36M | 42.58% |
Cash from investing | -3.72M | -84.38% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -21.08M | -137.83% |
Free cash flow | -10.62M | -14.87% |
About
Founded
2008
Headquarters
Website
Employees
78
